Medicine
Volume 36, Issue 4 , Pages 181-190 , April 2008

Drugs for airway disease

References 

  1. Global Initiative for Asthma . Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Available at: www.ginasthma.com2006;
  2. GOLD . Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management and prevention of COPD. GOLD. 2006;Available at: www.goldcopd.com(accessed 7 December 2007)
  3. Kips JC, Pauwels RA. Long-acting inhaled β2-agonist therapy in asthma. Am J Respir Crit Care Med. 2001;164:923–932
  4. Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur Resp Dis. 2007;29:587–595
  5. Nelson HS, Dorinsky PM. Safety of long-acting beta-agonists. Ann Intern Med. 2006;145:706–710
  6. Barnes PJ. Theophylline: new perspectives on an old drug. Am J Respir Crit Care Med. 2003;167:813–818
  7. Rennard SI. Treatment of stable chronic obstructive pulmonary disease. Lancet. 2004;364:791–802
  8. Barnes PJ. How corticosteroids control inflammation. Br J Pharmacol. 2006;148:245–254
  9. O’Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet. 2006;368:794–803
  10. Capra V, Ambrosio M, Riccioni G, Rovati GE. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities. Curr Med Chem. 2006;13:3213–3226
  11. Avila PC. Does anti-IgE therapy help in asthma? Efficacy and controversies. Annu Rev Med. 2007;58:185–203

PII: S1357-3039(08)00020-0

doi: 10.1016/j.mpmed.2008.01.007

Medicine
Volume 36, Issue 4 , Pages 181-190 , April 2008

Article Tools

* Image Usage & Resolution